SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-016955
Filing Date
2016-04-28
Accepted
2016-04-28 16:06:11
Documents
7
Period of Report
2016-06-23
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A cnat-def14a_20160623.htm DEF 14A 783842
2 GRAPHIC gu3sqlhgamzn000006.jpg GRAPHIC 64574
3 GRAPHIC gu3sqlhgamzn000002.jpg GRAPHIC 3442
4 GRAPHIC gu3sqlhgamzn000004.jpg GRAPHIC 3502
5 GRAPHIC gu3sqlhgamzn000005.jpg GRAPHIC 96232
6 GRAPHIC gu3sqlhgamzn000003.jpg GRAPHIC 4987
7 GRAPHIC gu3sqlhgamzn000001.jpg GRAPHIC 5419
  Complete submission text file 0001564590-16-016955.txt   1031310
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36003 | Film No.: 161600050
SIC: 2834 Pharmaceutical Preparations